Safety and Efficacy of Edaravone in Patients with Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-analysis Mengxia GaoLingqun ZhuFei Chen Systematic Review 03 December 2022 Pages: 1 - 11
Therapeutic Polypeptides and Peptidomimetics: Powerful Tools for COVID-19 Treatment Xinyu LiuJian ShiFei Chen Review Article 03 December 2022 Pages: 13 - 22
Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial Amy LeggNiamh MeagherSteven Y. C. Tong Original Research Article Open access 10 October 2022 Pages: 23 - 33
Correction to: Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial Amy LeggNiamh MeagherSteven Y. C. Tong Correction Open access 19 November 2022 Pages: 35 - 35
Pharmacokinetics and Safety of Follitropin Delta in Gonadotropin Down-Regulated Healthy Chinese Women Feng ShaoYi JiangDaniël Martijn Jonker Original Research Article Open access 07 December 2022 Pages: 37 - 44
Long-Term Safety and Effectiveness of Erenumab in Patients with Migraine: A Systematic Review and Single-Arm Meta-analysis Fernanda Ferreira BomtempoRebeka Bustamante RochaJoão Paulo Mota Telles Original Research Article 08 December 2022 Pages: 45 - 59
CHAnges in Diuretic Medication Prescribing and Surrogate Laboratory Parameters After Initiating EmpagliflOziN in Veterans (CHAMPION Cohort Study) Tanvi PatilEmily HalseyDavida Eppes Original Research Article 14 December 2022 Pages: 61 - 74
Gastric Glitch: A New Functional Disease Treated with Buspirone and Prucalopride in an N-of-1 Double-Blind Clinical Trial Gabriela AmbrósRicardo ValõesFernando Fornari Research Letter 12 November 2022 Pages: 75 - 78
Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression” Alina WilkowskaWiesław Jerzy Cubała Letter to the Editor 16 November 2022 Pages: 79 - 80
Correction to: Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression” Alina WilkowskaWiesław Jerzy Cubała Correction 02 December 2022 Pages: 81 - 81
Authors’ Response to Comment on “Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression” Julia Diniz GrossiJuliana SurjanAcioly Luiz Tavares Lacerda Letter to the Editor 25 November 2022 Pages: 83 - 84